✦ LIBER ✦

Giant cell arteritis: Involvement of intracranial arteries

✍ Scribed by Salvarani, Carlo ;Giannini, Caterina ;Miller, Dylan V. ;Hunder, Gene

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 131 KB
Volume: 55
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.22359

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Arterial wall injury in giant cell arter

Arterial wall injury in giant cell arteritis

✍ Cornelia M. Weyand; Jörg J. Goronzy 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB 👁 2 views

Vascular disease is the leading cause of death and disability in the Western world. In most cases, tissue ischemia results from the accretion of atherosclerotic plaque. Eventually, blood flow is compromised, and ischemia of dependent organs follows. Arterial wall inflammation is not a primary pathog

Pathogenesis of giant cell arteritis

✍ Gene G. Hunder; J. T. Lie; Jörg J. Goronzy; Cornelia M. Weyand 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 485 KB 👁 2 views

Treatment of resistant giant cell arteri

Treatment of resistant giant cell arteritis

✍ L. A. Healey; K. R. Wilske 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 2 views

Presentation of occult giant cell arteri

Presentation of occult giant cell arteritis

✍ Louis A. Healey; Kenneth R. Wilske 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 284 KB 👁 2 views

Expression of interleukin-32 in the infl

Expression of interleukin-32 in the inflamed arteries of patients with giant cell arteritis

✍ Francesco Ciccia; Riccardo Alessandro; Aroldo Rizzo; Simona Principe; Francesca 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 458 KB 👁 2 views

Giant cell arteritis without clinically

Giant cell arteritis without clinically evident vascular involvement in a defined population

✍ Gonzalez-Gay, Miguel A. ;Garcia-Porrua, Carlos ;Amor-Dorado, Juan C. ;Llorca, Ja 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB 👁 2 views

## Objectives: To examine the frequency and clinical presentation of biopsy-proven giant cell arteritis (gca) patients who do not exhibit overt clinical vascular manifestations. to assess whether differences exist between this group of patients and the rest of biopsy-proven gca patients. ## Method